ALX Leadership Tuesday, June 30, 2026 +0.70 Positive

ALX Oncology appoints Scott Garland as Chairman and Michael Listgarten as General Counsel

ALX Oncology has appointed Scott Garland as Chairman and Michael Listgarten as General Counsel. This executive shuffle strengthens the company's leadership team as it advances its clinical pipeline.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day